HB 0007B 2003
   
1 A bill to be entitled
2          An act relating to public records and public meetings
3    exemptions; amending s. 1004.445, F.S.; creating a public
4    records exemption for proprietary confidential business
5    information owned or controlled by the Florida Alzheimer's
6    Center and Research Institute; categorizing specified
7    types of information as proprietary confidential business
8    information; defining "managed care"; providing for access
9    to proprietary confidential business information by
10    specified agencies; creating a public meetings exemption
11    for specified meetings or portions of meetings of the
12    governing board of the Florida Alzheimer’s Center and
13    Research Institute; providing for future review and repeal
14    of the exemption; providing a statement of public
15    necessity; providing for construction of the act in pari
16    materia with laws enacted during the 2003 Regular Session
17    or the 2003 Special Session A of the Legislature;
18    providing an effective date.
19         
20          Be It Enacted by the Legislature of the State of Florida:
21         
22          Section 1. Subsection (9) of section 1004.445, Florida
23    Statutes, is amended, and subsection (10) is added to said
24    section, to read:
25          1004.445 Florida Alzheimer's Center and Research
26    Institute.--
27          (9)(a)The following information is confidential and
28    exempt from the provisions of s. 119.07(1) and s. 24(a), Art. I
29    of the State Constitution:
30          1.(a)Personal identifying information relating to clients
31    of programs created or funded through the Florida Alzheimer's
32    Center and Research Institute which is held by the institute,
33    the University of South Florida, or theState Board of Education
34    or by persons who provide services to clients of programs
35    created or funded through contracts with the Florida Alzheimer's
36    Center and Research Institute;
37          2.(b) Any medical or health records relating to patients
38    heldwhich may be created or received by the institute; and
39          3.(c)Proprietary confidential business information. As
40    used in this subparagraph, the term "proprietary confidential
41    business information” means information, regardless of its form
42    or characteristics, which is owned or controlled by the
43    institute; is intended to be and is treated by the institute as
44    private and the disclosure of which would harm the business
45    operations of the institute; has not been intentionally
46    disclosed by the institute unless pursuant to law, an order of a
47    court or administrative body, a legislative proceeding pursuant
48    to s. 5, Art. III of the State Constitution, or a private
49    agreement that provides that the information may be released to
50    the public; and which is information concerning:
51          a.Materials that relate to methods of manufacture or
52    production, potential trade secrets, potentially patentable
53    material, actual trade secrets as defined in s. 688.002, or
54    proprietary information received, generated, ascertained, or
55    discovered during the course of research conducted by or through
56    the institute and business transactions resulting from such
57    research;
58          b.(d) The identity of a donor or prospective donor to the
59    instituteFlorida Alzheimer's Center and Research Institutewho
60    wishes to remain anonymous, and all information identifying such
61    donor or prospective donor;
62          c.(e)Any information received by the institute in the
63    performance of its duties and responsibilities which is
64    otherwise confidential and exempt by law; and
65          d.(f)Any information received by the institute from a
66    person from this oranother state or nation or the Federal
67    Government which is otherwise exempt or confidential or exempt
68    pursuant to this or anotherthatstate's or nation's laws or
69    pursuant to federal law;
70          e. Internal auditing controls and reports of internal
71    auditors;
72          f. Contracts for managed-care arrangements, including
73    preferred provider organization contracts, health maintenance
74    organization contracts, and exclusive provider organization
75    contracts, and any documents directly relating to the
76    negotiation, performance, and implementation of any such
77    contracts for managed-care arrangements;
78          g. Bids or other contractual data, banking records, and
79    credit agreements the disclosure of which would impair the
80    efforts of the institute to contract for goods or services on
81    favorable terms;
82          h. Information relating to private contractual data, the
83    disclosure of which would impair the competitive interest of the
84    provider of the information;
85          i. Corporate officer and employee personnel information;
86          j. Information relating to the proceedings and records of
87    the credentialing panels and committees and of the governing
88    board of the institute relating to credentialing;
89          k. Minutes of meetings of the governing board of the
90    institute, except minutes of meetings open to the public
91    pursuant to subsection (10); and
92          l. Information that reveals plans for marketing services
93    that the institute reasonably expects to be provided by
94    competitors.
95         
96          As used in this subparagraph, the term "managed care” means
97    systems or techniques generally used by third-party payors or
98    their agents to affect access to and control payment for health
99    care services. Managed-care techniques most often include one or
100    more of the following: prior, concurrent, and retrospective
101    review of the medical necessity and appropriateness of services
102    or site of services; contracts with selected health care
103    providers; financial incentives or disincentives related to the
104    use of specific providers, services, or service sites;
105    controlled access to and coordination of services by a case
106    manager; and payor efforts to identify treatment alternatives
107    and modify benefit restrictions for high-cost patient care.
108          (b) The Auditor General, the Office of Program Policy
109    Analysis and Government Accountability, and the State Board of
110    Education, pursuant to their oversight and auditing functions,
111    must be given access to all proprietary confidential business
112    information upon request and without subpoena and must maintain
113    the confidentiality of information so received.
114          (c)Any governmental entity that demonstrates a need to
115    access such confidential and exempt information in order to
116    perform its duties and responsibilities shall have access to
117    such information and shall otherwise keep such information
118    confidential and exempt. This section is subject to the Open
119    Government Sunset Review Act of 1995 in accordance with s.
120    119.15 and shall stand repealed on October 2, 2006, unless
121    reviewed and saved from repeal through reenactment by the
122    Legislature.
123          (10) Meetings or portions of meetings of the governing
124    board of the Florida Alzheimer’s Center and Research Institute
125    at which information is discussed that is made confidential and
126    exempt pursuant to subsection (9) are exempt from s. 286.011 and
127    s. 24(b), Art. I of the State Constitution.
128          Section 2. Subsections (9) and (10) of s. 1004.445,
129    Florida Statutes, are subject to the Open Government Sunset
130    Review Act of 1995 in accordance with s. 119.15, Florida
131    Statutes, and shall stand repealed on October 2, 2008, unless
132    reviewed and saved from repeal through reenactment by the
133    Legislature.
134          Section 3. The Legislature finds that it is a public
135    necessity that proprietary confidential business information
136    owned or controlled by the Florida Alzheimer's Center and
137    Research Institute; internal auditing controls and reports of
138    internal auditors; contracts for managed-care arrangements and
139    any documents directly relating to the negotiation, performance,
140    and implementation of any such contracts for managed-care
141    arrangements; bids or other contractual data, banking records,
142    and credit agreements; information relating to private
143    contractual data; corporate officer and employee personnel
144    information; information relating to the proceedings and records
145    of the credentialing panels and committees and of the governing
146    board of the Florida Alzheimer's Center and Research Institute
147    relating to credentialing; minutes of meetings of the governing
148    board of the institute; and information that reveals plans for
149    marketing services that the institute reasonably expects to be
150    provided by competitors be made confidential and exempt from
151    public disclosure. The institute must compete directly with its
152    private-sector counterparts. Its economic survival depends on
153    the institute’s ability to so compete. As such, these exemptions
154    are necessary because release of such information and records
155    would adversely impact the institute in the competitive health
156    care and medical research environment. Disclosure of such
157    information and records would place the institute on an unequal
158    footing in the marketplace as compared with private health care
159    providers that are not required to disclose such confidential
160    and exempt information and records. The highly confidential
161    nature of Alzheimer-related research discoveries necessitates
162    that the institute be authorized to maintain confidential
163    information it receives from, or generates for, the sponsors of
164    its research. Accordingly, disclosure of such information and
165    records would impede the effective and efficient administration
166    of the Florida Alzheimer’s Center and Research Institute and
167    would create an unfair competitive advantage for persons or
168    entities receiving such information. Also, such information and
169    records contain information of a sensitive, personal nature
170    regarding corporate officers and employees. Disclosure of such
171    information could be harmful to the officer or employee. It is
172    likewise a public necessity that the meetings of the governing
173    board of the institute be closed in order to protect the
174    competitive interest of the institute and to guarantee the
175    ability of the governing board to fulfill its Alzheimer’s
176    disease research and teaching mission for the benefit of the
177    public. Closing access to such board meetings enables the boards
178    to be more open and frank in the information so provided and
179    discussed without the attendant fear that honest and truthful
180    exchange of information will result in the public dissemination
181    of information discussed that could be used to harm the
182    institute and its members. Furthermore, disclosing information
183    and records made confidential and exempt pursuant to the
184    institute’s public records exemption via an open meeting defeats
185    the purpose of the public records exemption.
186          Section 4. If any law amended by this act was also amended
187    by a law enacted at the 2003 Regular Session of the Legislature
188    or at the 2003 Special Session A of the Legislature, such laws
189    shall be construed as if they had been enacted at the same
190    session of the Legislature, and full effect shall be given to
191    each if possible.
192          Section 5. This act shall take effect upon becoming a law.